Risk of Infections Associated With MS and Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Mult. Scler. 2022 Feb 23;[EPub Ahead of Print], C Tur, AL Dubessy, S Otero-Romero, MP Amato, T Derfuss, F Di Pauli, E Iacobaeus, M Mycko, H Abboud, A Achiron, A Bellinvia, A Boyko, JL Casanova, D Clifford, R Dobson, MF Farez, M Filippi, KC Fitzgerald, M Fonderico, R Gouider, Y Hacohen, K Hellwig, B Hemmer, L Kappos, F Ladeira, C Lebrun-Frénay, C Louapre, M Magyari, M Mehling, C Oreja-Guevara, L Pandit, C Papeix, F Piehl, E Portaccio, I Ruiz-Camps, K Selmaj, S Simpson-Yap, A Siva, PS Sorensen, MP Sormani, M Trojano, A Vaknin-Dembinsky, S Vukusic, B Weinshenker, H Wiendl, A Winkelmann, MI Zuluaga Rodas, M Tintoré, B StankoffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.